论文部分内容阅读
目的:通过采用炎琥宁和培菲康对小儿呼吸内科支气管肺炎患者进行治疗,并观察和记录治疗效果。方法:随机选取我院2013年1月~2015年1月来我院治疗小儿内科支气管炎的患者178例,并将其随机均分为两组,每组各89例,将第一组作为对照组,对该组患者采用传统常规方式进行治疗;将第二组作为观察组,对该组患者采用常规治疗方法的基础上加上炎琥宁和培菲康进行治疗。同时进行一段时间的治疗,在治疗期间,及时观察和记录患者的病情变化及不良反应,并对其不良反应进行及时护理。结果:通过对临床记录结果的研究和分析,观察组患者的治疗效果明显优于对照组,即采用炎琥宁和培菲康治疗小儿内科支气管炎具有显著的临床治疗效果。结论:采用炎琥宁和培菲康治疗小儿内科支气管炎具有较好的治疗效果,大大减轻了患者的病痛,具有重要的临床价值,值得推广和应用于临床。
OBJECTIVE: To treat patients with pediatric respiratory medicine bronchopneumonia by using Yan Hu Ning and Pefikang, and to observe and record the therapeutic effect. Methods: A total of 178 patients with pediatric bronchitis in our hospital from January 2013 to January 2015 were randomly selected and randomly divided into two groups (n = 89 in each group). The first group served as control Group, the group of patients treated by conventional methods; the second group as the observation group, the group of patients using conventional treatment methods based on the addition of Yan Hu Ning and Peifu Kang for treatment. At the same time for a period of treatment, during treatment, timely observation and record of patients with changes in the condition and adverse reactions, and timely treatment of adverse reactions. Results: Through the study and analysis of clinical records, the treatment effect of the observation group was significantly better than that of the control group, that is, the treatment of infantile bronchitis by Yan Hu Ning and Peifu Kang had significant clinical therapeutic effect. Conclusion: The treatment of infantile bronchitis by Yan Hu Ning and Peifu Kang has a good therapeutic effect, greatly reducing the patient’s pain, has important clinical value, it is worth to promote and apply in clinical.